By Juan Carlos Rodriguez (May 12, 2014, 5:02 PM EDT) -- A New York federal judge on Friday rejected Novartis Pharmaceuticals Corp.'s attempt to sink a suit alleging its bone drugs Zometa and Aredia caused jaw injuries to a patient with debilitating bone diseases, finding a jury needs to decide critical questions.
Brian Bee and his wife, Donna Bee, allege in their suit that Zometa and Aredia, prescribed to Brian Bee as part of a regimen to treat his ankylosing spondylitis, osteoporosis, and bone pain, caused him to develop osteonecrosis of the jaw, or ONJ. Novartis sought summary judgment based on its argument that the Bees had failed to back up their failure-to-warn...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!